ProfileGDS4718 / 243916_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 71% 65% 71% 63% 74% 72% 81% 69% 68% 71% 76% 75% 74% 74% 79% 70% 72% 73% 77% 73% 66% 70% 72% 71% 72% 73% 71% 75% 67% 82% 77% 73% 67% 74% 83% 76% 76% 68% 63% 73% 69% 75% 73% 77% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.9478571
GSM549102patient 115, normal, homogenized [OPG study]6.4477565
GSM549104patient 119, normal, homogenized [OPG study]7.0259371
GSM549108patient 138, normal, homogenized [OPG study]6.3442963
GSM549119patient 077, normal, homogenized [OPG study]7.2136174
GSM549133patient 032, cancer, homogenized [OPG study]7.1158772
GSM549139patient 042, cancer, homogenized [OPG study]8.0510681
GSM549099patient 107, normal, homogenized [OPG study]6.729169
GSM549109patient 139, normal, homogenized [OPG study]6.7191568
GSM549110patient 046, normal, homogenized [OPG study]6.9456171
GSM549114patient 063, normal, homogenized [OPG study]7.4719676
GSM549122patient 082, normal, homogenized [OPG study]7.2995175
GSM549134patient 033, cancer, homogenized [OPG study]7.2479174
GSM549136patient 036, cancer, homogenized [OPG study]7.3121674
GSM549140patient 044, cancer, homogenized [OPG study]7.8164879
GSM549111patient 047, normal, homogenized [OPG study]6.9226170
GSM549113patient 057, normal, homogenized [OPG study]7.0802872
GSM549132patient 031, cancer, homogenized [OPG study]7.1723373
GSM549137patient 038, cancer, homogenized [OPG study]7.6078477
GSM549142patient 047, cancer, homogenized [OPG study]7.0531173
GSM549100patient 110, normal, homogenized [OPG study]6.5201766
GSM549107patient 135, normal, homogenized [OPG study]6.8649270
GSM549115patient 068, normal, homogenized [OPG study]7.0535472
GSM549116patient 072, normal, homogenized [OPG study]7.0258271
GSM549120patient 078, normal, homogenized [OPG study]7.0684672
GSM549131patient 030, cancer, homogenized [OPG study]7.1956873
GSM549118patient 074, normal, homogenized [OPG study]6.9679771
GSM549129patient 027, cancer, homogenized [OPG study]7.3741275
GSM549123patient 088, normal, homogenized [OPG study]6.625167
GSM549124patient 006, cancer, homogenized [OPG study]8.0026382
GSM549126patient 015, cancer, homogenized [OPG study]7.5094877
GSM549128patient 025, cancer, homogenized [OPG study]7.199173
GSM549103patient 117, normal, homogenized [OPG study]6.6009667
GSM549117patient 073, normal, homogenized [OPG study]7.2013774
GSM549138patient 041, cancer, homogenized [OPG study]8.2599983
GSM549141patient 045, cancer, homogenized [OPG study]7.5659576
GSM549130patient 028, cancer, homogenized [OPG study]7.3581976
GSM549101patient 111, normal, homogenized [OPG study]6.7349868
GSM549105patient 128, normal, homogenized [OPG study]6.3424163
GSM549106patient 134, normal, homogenized [OPG study]7.2521473
GSM549112patient 048, normal, homogenized [OPG study]6.7885369
GSM549125patient 011, cancer, homogenized [OPG study]7.3440675
GSM549127patient 024, cancer, homogenized [OPG study]7.2449673
GSM549135patient 035, cancer, homogenized [OPG study]7.6063577